clozapine-induced agranulocytosis Jewish patients schizophrenia Agranulocytosis patients chronic schizophrenia atypical neuroleptic drug clozapine Previous studies mechanism risk factors adverse reaction observed association Jewish ethnic background development agranulocytosis patient sample clozapine refractory symptoms HLA typing patients agranulocytosis phenotype patients agranulocytosis clozapine-treated patients agranulocytosis part haplotype Ashkenazi Jewish population frequencies combined alleles incidence patients agranulocytosis patients control patients Ashkenazi Jewish ancestry patients findings genetic factors major histocompatibility complex haplotypes susceptibility Jewish schizophrenic patients clozapine agranulocytosis gene products haplotype drug toxicity 